USFDA accepts Sun Pharma arm's ophthalmic drug application

Sun Pharma said that post the USFDA approval, OTX-101 will be commercialised in the US by Sun Ophthalmics, the branded ophthalmics division of Sun Pharma.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news